急性呼吸窘迫综合征是可预防的疾病吗?
该叙述性综述在ARDS首次描述六十年后,评估ARDS是否可预防。文章以多重打击假说为框架,综合临床试验、人群流行病学研究、实施研究和生物学亚表型研究。结果显示:医源性表型预防已大幅成功——男性为主血浆政策后输血相关急性肺损伤显著下降,急诊和手术室启动的肺保护性通气降低ARDS发生率和死亡率,集束化护理进一步减少医源性肺损伤;非医源性ARDS因宿主-病原体交互和生物学表型异质性,未选择人群的药物预防试验持续令人失望。作者结论:将预防扩展到医源性病因之外需要精准方法——表型靶向药物治疗、个体化机械通气和系统实施循证实践。
要点
- 男性为主血浆政策实施后,输血相关急性肺损伤显著下降,是医源性ARDS预防成功的范例。
- 在急诊科和手术室启动肺保护性通气可降低ARDS发生率和死亡率。
- 集束化护理(限制性液体与输血策略、误吸预防、早期抗微生物药物)进一步减少医源性肺损伤。
- 未选择人群的药物预防试验持续令人失望,可能因生物学亚表型对治疗反应不同。
- ARDS死亡的人群归因分数有限,即使预防成功也可能不转化为成比例死亡率下降。
适用人群与场景
- 适用于急诊科、手术室及ICU中具有医源性肺损伤风险(输血、机械通气、误吸、感染)的患者,以及非医源性ARDS病因(宿主-病原体交互驱动)人群。
处置流程与药物剂量
- 医源性ARDS预防措施包括:男性为主血浆政策、急诊和手术室启动肺保护性通气、集束化护理(限制性液体与输血策略、误吸预防、早期抗微生物药物)。
- 非医源性ARDS的预防方向为精准方法:表型靶向药物治疗、个体化机械通气、在全程医疗中系统实施循证实践(作者结论)。
研究设计与关键结果
- 叙述性综述,以多重打击假说为框架综合临床试验、人群流行病学、实施研究和生物学亚表型研究证据。
- 医源性表型:男性为主血浆政策后输血相关急性肺损伤显著下降;急诊和手术室启动肺保护性通气降低ARDS发生率和死亡率;集束化护理进一步减少医源性肺损伤。
- 非医源性ARDS:未选择人群的药物预防试验持续令人失望;ARDS死亡的人群归因分数有限。
证据类型、等级与局限
- 证据类型:叙述性综述,综合临床试验、人群流行病学研究、实施研究和生物学亚表型研究。
- 局限:原文未报告局限性
对床旁实践的改变
- 支持在急诊科和手术室即启动肺保护性通气以降低ARDS发生率和死亡率。
- 支持采用男性为主血浆政策以减少输血相关急性肺损伤。
- 支持集束化护理(限制性液体与输血策略、误吸预防、早期抗微生物药物)减少医源性肺损伤。
- 作者认为,非医源性ARDS预防需表型靶向药物治疗、个体化机械通气和系统实施循证实践。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Sixty years after its initial description, the epidemiology and pathophysiology of acute respiratory distress syndrome (ARDS) have evolved substantially. This narrative review examines whether ARDS is a preventable disease, evaluating the evidence for successful prevention of iatrogenic phenotypes and the challenges that remain for noniatrogenic causes.
METHODS: We reviewed the published literature on ARDS prevention, including evidence from clinical trials, population-based epidemiologic studies, implementation research, and biological subphenotyping studies, synthesized through the framework of the multiple hit hypothesis.
RESULTS: For iatrogenic phenotypes, ARDS prevention has substantially succeeded. Transfusion-related acute lung injury has declined dramatically following male-predominant plasma policies. Lung-protective ventilation initiated in emergency departments and operating rooms has reduced both ARDS incidence and mortality. Bundled care approaches combining restrictive fluid and transfusion strategies, aspiration precautions, and early antimicrobials have further reduced iatrogenic lung injury. What remains under the ARDS label is an increasingly heterogeneous collection of conditions driven by upstream host-pathogen interactions and biological phenotype. Pharmacologic prevention trials in unselected populations have been consistently disappointing, likely because biologically distinct subphenotypes respond differently to treatment. Additionally, the population-attributable fraction of death from ARDS is modest, suggesting that even successful prevention may not translate into proportional mortality reduction.
CONCLUSION: Extending prevention beyond iatrogenic causes will require precision approaches: phenotype-targeted pharmacotherapy, individualized mechanical ventilation, and systematic implementation of evidence-based practices across the care continuum.
参考来源
- Yadav H, Marini JJ, Gajic O, et al. Is acute respiratory distress syndrome a preventable disease? Intensive Care Med. 2026. PMID: 42257879. doi:10.1007/s00134-026-08493-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。